Experience

Davis Polk, together with Slaughter and May, is advising Shire plc in connection with a recommended cash and stock offer for Shire’s entire share capital by Takeda Pharmaceutical Company…

Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Five9, Inc. of an aggregate principal amount of …

Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $1.3 billion aggregate principal amount of 4.150% notes due 2048. Texas Instruments is a global…

Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 5,000,000 shares of common stock of Unity Biotechnology, Inc. Unity…

Davis Polk advised the joint global coordinators in the Hong Kong initial public offering of Ping An Healthcare and Technology Company Limited. The gross proceeds from the offering…

Davis Polk advised Charles Taylor plc on a placing of new shares representing approximately 9.75% of its current issued share capital which raised gross proceeds of approximately £17.6…

Davis Polk advised Sixsigma Networks México, S.A. de C.V. (“KIO Networks”) in connection with its Rule 144A/Regulation S offering of $300 million aggregate principal amount of its 7.500%…

Davis Polk advised the initial purchaser in connection with the Singapore dollar $150 million Regulation S offering by Central China Real Estate Limited of its 6.25% senior notes due…

Davis Polk advised CNOOC Limited as to U.S. and Hong Kong law in connection with the SEC-registered offering of guaranteed notes by CNOOC Finance (2015) U.S.A. LLC, a wholly owned…

Davis Polk advised the bookrunners and representatives of the several initial purchasers in connection with the 144A/Regulation S notes offering by Bacardi Limited of $750 million…